Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04674852 · ClinicalTrials.gov registry record · NA
Mayo Designed Soft Tissue Ultrasound-Detectable Marker
A NA study of Breast Neoplasm Female and Ultrasound Therapy; Complications, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT04674852 is a NA study of Breast Neoplasm Female and Ultrasound Therapy; Complications that has completed, run by Mayo Clinic. The registered enrollment target is 8 participants, below the 179-participant average among 8 other Breast Neoplasm Female trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04674852, a NA study of Breast Neoplasm Female and Ultrasound Therapy; Complications, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
Researchers are trying to determine if the Mayo marker is easily seen with ultrasound making it easier, faster, and more accurate for preoperative localization of the biopsied positive lymph node.
Conditions Studied
Interventions
- DEVICE Research Marker
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-11-02 |
| Est. Completion | 2022-04-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04674852
The ClinicalTrials.gov registry entry for NCT04674852 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 179-participant average among 8 other Breast Neoplasm Female trials with a reported enrollment target (96% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Breast Neoplasm Female appearing as the primary indexed condition, and to 1 intervention - of which Research Marker is the first listed.
NCT04674852 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT04674852 about?
NCT04674852 is a clinical study titled "Mayo Designed Soft Tissue Ultrasound-Detectable Marker". Researchers are trying to determine if the Mayo marker is easily seen with ultrasound making it easier, faster, and more accurate for preoperative localization of the biopsied positive lymph node.
What is the current status of trial NCT04674852?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2020-11-02. Estimated completion is 2022-04-07.
What conditions does trial NCT04674852 study?
This clinical trial studies the following conditions: Breast Neoplasm Female, Ultrasound Therapy; Complications.
What interventions are being tested in trial NCT04674852?
The interventions under investigation include: Research Marker (DEVICE).
Who is sponsoring clinical trial NCT04674852?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04674852 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Neoplasm Female
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy
RECRUITING · NA
-
The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
RECRUITING · NA
-
Study on Physical Activity's Relationship With Cancer and Cognition
COMPLETED · NA
-
Web-Base App To Improve Aromatase Inhibitor Adherence
COMPLETED · NA
-
THRIVE Breast Cancer App Study
COMPLETED · NA
-
Neoadjuvant Weekly Paclitaxel and Biomarkers of Therapy Response
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.